₂H Ogier de Baulny

Summary for 2004 [at-glance overview of H Ogier de Baulny work for the selected year as suggested by data mining algorithms]

This is an Authoratory overview of author H Ogier de Baulny. According to available data, in 2004 H Ogier de Baulny published at least 2 articles. This work was completed in collaboration with several authors including Grimaldi, M and Geneviève, D. Many other authors have collaborated with H Ogier de Baulny as well. There is no information about the funding or the grants awarded to support this work.

Analysis of the article abstracts and the titles suggests that H Ogier de Baulny professional interests are focused around "myopathic form coenzyme", "despite replacement myopathic" and "form coenzyme q10". These might also be referred to as "coenzyme q10", "q10 defect" or "form coenzyme". Statistical analysis shows that H Ogier de Baulny's writing is likely to contains terms "despite", "q10", "coenzyme", "coq10", "treatment" and "myopathic".

Unfortunately, there is not enough information to establish H Ogier de Baulny affiliation. Luckily, one email address is on file.

EN FR ES RU

Inaccurate information, needs improvement

make correction leave comment ask question

Images [images we found on the Internet for H Ogier de Baulny]

Do you know H Ogier de Baulny who matches the profile above? Click the photo and let us know!

Alternative names (1) [other authors with names similar to H Ogier de Baulny]

₈Ogier de Baulny, Hélène

Year 2004 Charts [H Ogier de Baulny frequent coauthors and the most common unique vocabulary terms for the selected year]

Historical Performance Charts [graphical overview of H Ogier de Baulny publication and funding history for the range of years]

Emails (1) [email addresses extracted from H Ogier de Baulny affiliations]

hidden to prevent spam, click here to reveal

H Ogier de Baulny Coauthors (13) [all coauthors with the number of joint publications]

1

1

1

1

1

1

1

1

1

1

1

1

1

Other [context-specific ads]

Affiliations (2) [condensed summary of the H Ogier de Baulny affiliations, the leading number and the color conveys importance]

₁INSERM U582, Institut de Myologie, Groupe hospitalier Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, France.
₁Centre de Génétique, CHU, Dijon, France.

Key Opinion Leader In [H Ogier de Baulny is considered a key opinion leader in any keyword where the rank of 5 is achieved, the leading number before the keyword shows the author's rank as compared to all other authors]

no keywords assigned

Keywords (27) [keywords assigned to H Ogier de Baulny articles by PubMed, the leading number and the color conveys importance]

₂Humans | ₁Cerebellum | ₁Infant, Newborn | ₁Follow-Up Studies | ₁Lactates | ₁Vomiting | ₁Child, Preschool | ₁Benzoquinones | ₁Muscle, Skeletal | ₁Magnetic Resonance Imaging | ₁Exercise Tolerance | ₁Thiamine Deficiency | ₁Time Factors | ₁Thiamine | ₁Carnitine | ₁Infant | ₁Drug Therapy, Combination | ₁Parenteral Nutrition, Total | ₁Female | ₁Acidosis, Lactic | ₁Mitochondrial Myopathies | ₁Cerebellar Ataxia | ₁Treatment Failure | ₁Ubiquinone | ₁Treatment Outcome | ₁Mitochondria, Muscle | ₁Disease Progression

H Ogier de Baulny Unique Vocabulary (96) [single words, word pairs and phrases obtained by analysis of abstracts and titles, the leading number and the color conveys importance; H Ogier de Baulny might be a good expert witness on these terms]

₃despite | ₃q10 | ₃coenzyme | ₃coq10 | ₃treatment | ₂myopathic | ₂progression | ₂deficiency | ₂form | ₂supplementation | ₂report | ₂defect | ₂replacement | ₁cerebellar | ₁symptoms | ₁defects | ₁worsening | ₁subsequent | ₁resulted | ₁progressive | ₁may | ₁clinical | ₁severe | ₁neonates | ₁acidosis | ₁patient | ₁markedly | ₁evaluation | ₁acute | ₁disease | ₁switch | ₁exercise
₃coenzyme q10 | ₂q10 defect | ₂form coenzyme | ₂despite replacement | ₂progression despite | ₂myopathic form | ₂replacement myopathic | ₁treatment resulted | ₁metabolic worsening | ₁substitutive treatment | ₁supplementation prevent | ₁despite supplementation | ₁coq10 treatment | ₁initial symptoms | ₁evaluation patient | ₁improved markedly | ₁coq10 deficiency | ₁parenteral nutrition | ₁severe | ₁lactic acidosis | ₁defect initial | ₁authors report | ₁acute thiamin | ₁q10 coq10 | ₁exercise intolerance | ₁follow-up evaluation | ₁years follow-up | ₁progressive neurologic | ₁markedly substitutive | ₁switch | ₁may cause | ₁clinical metabolic
₂myopathic form coenzyme | ₂despite replacement myopathic | ₂form coenzyme q10 | ₂coenzyme q10 defect | ₂progression despite replacement | ₂replacement myopathic form | ₁treatment resulted clinical | ₁defect authors report | ₁coq10 defects may | ₁coq supplementation prevent | ₁supplementation progression despite | ₁initial symptoms exercise | ₁supplementation prevent onset | ₁exercise intolerance hyperlactatemia | ₁q10 coq10 deficiency | ₁patient coenzyme q10 | ₁severe lactic acidosis | ₁onset cerebellar syndrome | ₁symptoms exercise intolerance | ₁worsening disappeared subsequent | ₁severe | ₁neonates unsupplemented total | ₁acidosis acute thiamin | ₁idebenone treatment resulted | ₁report neonates unsupplemented | ₁prevent onset cerebellar | ₁unsupplemented total parenteral | ₁switch | ₁resulted clinical metabolic | ₁markedly substitutive treatment | ₁neurologic disease despite | ₁authors report years

Reader's Comments (0) [comments posted by readers of H Ogier de Baulny profile]